Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Hasan Burak İşleyen։ Thrombocytopenia and Mortality in Critically Ill Cancer Patients
Nov 20, 2026, 14:02

Hasan Burak İşleyen։ Thrombocytopenia and Mortality in Critically Ill Cancer Patients

Hasan Burak İşleyen, Cardiologist, Academic Editor at PLOS ONE, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cardio-Oncology, adding:

“Pleased to share our original research published in Cardio-Oncology: ‘ICU-onset atrial fibrillation surrogate, thrombocytopenia, and short-term outcomes in patients with cancer requiring intensive care.’

Cancer, atrial fibrillation, thrombocytopenia, and critical illness create a particularly complex intersection of thrombotic, bleeding, and mortality risks.

Among 9,640 cancer ICU stays, severe thrombocytopenia identified the subgroup in which the ICU-onset atrial fibrillation surrogate showed the clearest adjusted mortality signal. Because atrial fibrillation and clinical outcomes were identified from structured data rather than adjudicated events, these findings should be interpreted as hypothesis-generating rather than causal.

I am grateful to my co-authors and to Cardio-Oncology for providing a rigorous multidisciplinary forum at the intersection of cardiovascular medicine, oncology, and critical care.”

Title: ICU-onset atrial fibrillation surrogate, thrombocytopenia, and short-term outcomes in patients with cancer requiring intensive care: a retrospective ICU cohort study

Authors: Hasan Burak Isleyen, Sevil Tugrul Yavuz, Sercan Bulut, Fatih Kizkapan, Cevahir Alioglu, Erdem Sunger, Ertugrul Okuyan

Hasan Burak İşleyen։ Thrombocytopenia and Mortality in Critically Ill Cancer Patients

Stay updated with Hemostasis Today.